State and territory funding for the intranasal flu vaccine in 2026 FluMist live attenuated influenza vaccine (LAIV) has been approved for use in Australia for children aged 2 to <18 years. The following table outlines vaccine availability, funding eligibility and useful links for all states and territories. State/territory Funded groups and availability Useful links Australian Capital Territory Available on private market for children and adolescents aged 2 to <18 years Where to get the influenza vaccine – ACT GovernmentNew South Wales Funded for children aged 2 to <5 yearsAvailable on private market for children and adolescents aged 2 to <18 years 2026 NSW Intranasal Flu Program – NSW HealthNorthern Territory Available on private market for children and adolescents aged 2 to <18 yearsFlu vaccination – Northern Territory GovernmentQueensland Funded for children aged 2 to 5 years (inclusive) Available on private market for children and adolescents aged 2 to <18 years 2026 Queensland Nasal Spray Flu Immunisation Program – Queensland HealthSouth Australia Funded for children aged between 2 to <5 yearsAvailable on private market for children and adolescents aged 2 to <18 years Influenza Immunisation Program – SA HealthTasmania Available on private market for children and adolescents aged 2 to <18 years Flu vaccination – Tasmanian Department of HealthVictoria Available on private market for children and adolescents aged 2 to <18 years Seasonal influenza vaccine – Victorian Department of HealthWestern Australia Funded for children aged 2 to <12 yearsAvailable on private market for children and adolescents aged 2 to <18 years Health Announcement – Western Australia Department of HealthInfluenza immunisation – Western Australia Department of Health Back to influenza immunisation 1559 views
